Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-04

Clinical Trial Update: Pravastatin for Prevention of Preeclampsia [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating pravastatin for prevention of preeclampsia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pravastatin (pravastatin)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Preeclampsia | Phase 1 | Status: COMPLETED